We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of...
REDWOOD CITY, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of...
Advanced to Cohort 6 in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancersAbstract accepted for BDC-4182, a claudin 18.2-targeting BoltbodyTM ISAC at the...
BOLT SHAREHOLDER ALERT: Edelson Lechtzin LLP Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action PR...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0082 | -1.30158730159 | 0.63 | 0.655 | 0.6087 | 180067 | 0.6226567 | CS |
4 | -0.0592 | -8.69309838473 | 0.681 | 0.7 | 0.6087 | 140942 | 0.64956516 | CS |
12 | -0.1175 | -15.8934126877 | 0.7393 | 0.78 | 0.6087 | 167090 | 0.70476929 | CS |
26 | -0.4982 | -44.4821428571 | 1.12 | 1.56 | 0.6087 | 197292 | 0.85000983 | CS |
52 | -0.4882 | -43.981981982 | 1.11 | 1.56 | 0.6087 | 163383 | 0.93557707 | CS |
156 | -14.5982 | -95.914586071 | 15.22 | 15.22 | 0.6087 | 204019 | 2.47798375 | CS |
260 | -25.4782 | -97.6176245211 | 26.1 | 43.07 | 0.6087 | 212001 | 6.88811487 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions